Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Nasal Influenza Immunisation in Children with Asthma: The SNIFFLE 4 study
2016-002352-24Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, asthma, allergic asthma and 1 more, sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Change in asthma/wheeze symptom and disease control. Started May 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenzaasthmaallergic asthmawheeze
Beyond the preview
Go deeper on 2016-002352-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002352-24.